Skip to main content
Clinical Trials/NCT04338087
NCT04338087
Completed
Not Applicable

The Correlation Between Assisted Reproductive Technology and Male Erectile Dysfunction.

Rambam Health Care Campus1 site in 1 country734 target enrollmentJanuary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Erectile Dysfunction
Sponsor
Rambam Health Care Campus
Enrollment
734
Locations
1
Primary Endpoint
Changes in International index of erectile function score
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Men participating in assisted reproductive technology treatments will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth.

Detailed Description

Men participating in fertility will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth. In addition, participants will be questioned regarding marital life, sexual intercourse frequency, medical history and treatments for erectile dysfunction in relevant cases. Thes control group will be comprised of male subjects who did not require fertility treatments to conceive.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
March 1, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ROY LAUTERBACH MD

Principal Investigator

Rambam Health Care Campus

Eligibility Criteria

Inclusion Criteria

  • Participation in fertility treatments.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Changes in International index of erectile function score

Time Frame: From recruitment up to 3 years.

Changes in International index of erectile function score with a possible score ranging from 0 to 75. The higher the score, the better erectile function is.

Secondary Outcomes

  • Sexual intercourse rate.(From recruitment up to 3 years.)
  • Use of phospho-di-esterase 5 inhibitors(From recruitment up to 3 years.)

Study Sites (1)

Loading locations...

Similar Trials